Paulo Fontoura

13.2k citations
91 papers · 3.6k indexed · 4 hit papers · h-index 26
Topics
Alzheimer's disease research and treatments (24 papers)Multiple Sclerosis Research Studies (12 papers)Health Systems, Economic Evaluations, Quality of Life (10 papers)

In The Last Decade

Paulo Fontoura

86 papers receiving 3.5k citations

Hit Papers

A phase III randomized trial of gantenerumab in prodromal...20172026202020232017202120212024100200300400

Peers

Paulo Fontoura
Comparison fields: 5 of 116
  • Molecular Biology 1.1k
  • Pathology and Forensic Medicine 727
  • Physiology 726
  • Immunology 538
  • Genetics 448
Replace Ephrat Levy‐Lahad with:
Ephrat Levy‐Lahad Israel
Cinzia Dello Russo Italy
Bob Olsson Sweden
Jeffrey P. Greenfield United States
Chiara Fenoglio Italy
Carlo Ferrarese Italy
Martin Reichel Germany
Steven G. Kernie United States
Fabrizio Giuliani Canada
John R. Bethea United States
Paulo Fontoura relative to Ephrat Levy‐Lahad Israel Ephrat Levy‐Lahad's profile →
Citations per field
00.5×1.5×
Ephrat Levy‐Lahad · 1×
Citations per year

Countries citing papers authored by Paulo Fontoura

Since Specialization
Citations

This map shows the geographic impact of Paulo Fontoura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paulo Fontoura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paulo Fontoura more than expected).

Fields of papers citing papers by Paulo Fontoura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paulo Fontoura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paulo Fontoura. The network helps show where Paulo Fontoura may publish in the future.

Co-authorship network of co-authors of Paulo Fontoura

This figure shows the co-authorship network connecting the top 25 collaborators of Paulo Fontoura. A scholar is included among the top collaborators of Paulo Fontoura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paulo Fontoura. Paulo Fontoura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 8
2 0
3 14
4 3
5 70
6 18
7 75
8 0
9 93
10
A phase III randomized trial of gantenerumab in prodromal Alzheimer’s diseasebreakdown →
411
11 103
12 1
13 12
14 51
15 1
16 350
17 47
18 51
19 69
20 13

About Paulo Fontoura

Paulo Fontoura is a scholar working on Biological Psychiatry, Genetics and Physiology, having authored 91 papers that have together received 3.6k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (24 papers), Multiple Sclerosis Research Studies (12 papers) and Health Systems, Economic Evaluations, Quality of Life (10 papers). The work is most often cited by research in Biological Psychiatry (365 citations), Genetics (448 citations) and Pathology and Forensic Medicine (727 citations). Paulo Fontoura has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include Lawrence Steinman, Hideki Garren, Peggy P. Ho, Raymond A. Sobel, Lowen Y. Lee, Gregory Klein, Paul Delmar, Luca Santarelli, Carsten Hofmann and Omar Khwaja. Their work appears in journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026